tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TAK Stock Latest News

Firefly Neuroscience collaborates with Takeda, Novartis
The FlyFirefly Neuroscience collaborates with Takeda, Novartis
16h ago
NVS
TAK
Takeda receives European Commission approval for ADZYNMA
PremiumThe Fly
Takeda receives European Commission approval for ADZYNMA
1M ago
TAK
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
PremiumThe Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
1M ago
JNJ
TAK
AI Could Revolutionize Drug Discovery: A Look at Key Players 
PremiumMarket News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
2M ago
GS
TAK
Takeda Issues $500M Senior Note Due 2034
PremiumCompany Announcements
Takeda Issues $500M Senior Note Due 2034
3M ago
6K
TAK
Takeda Shareholders Approve Dividends and Directors
PremiumCompany AnnouncementsTakeda Shareholders Approve Dividends and Directors
3M ago
6K
TAK
Codexis enters asset purchase agreement with Crosswalk Therapeutics
Premium
The Fly
Codexis enters asset purchase agreement with Crosswalk Therapeutics
3M ago
TAK
CDXS
Takeda Advances Sustainable Pharma Innovation
Premium
Company Announcements
Takeda Advances Sustainable Pharma Innovation
3M ago
6K
TAK
Takeda: Japanese MHLW approves LIVTENCITY
PremiumThe Fly
Takeda: Japanese MHLW approves LIVTENCITY
3M ago
TAK
Takeda receives approval from European Commission for FRUZAQLA
PremiumThe Fly
Takeda receives approval from European Commission for FRUZAQLA
3M ago
TAK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
TAK
ARDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
TAK
AVTE
Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
PremiumThe FlyApple downgraded, Kroger upgraded: Wall Street’s top analyst calls
3M ago
KR
GSK
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
Premium
The Fly
Ovid Therapeutics price target lowered to $3 from $9 at B. Riley
3M ago
TAK
OVID
Takeda presents long-term data from Phase 3 ADVANCE-CIDP 3 trial of HYQVIA
Premium
The Fly
Takeda presents long-term data from Phase 3 ADVANCE-CIDP 3 trial of HYQVIA
3M ago
TAK
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
PremiumThe Fly
Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses
3M ago
TAK
OVID
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
PremiumThe Fly
Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg
3M ago
TAK
OVID
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
PremiumThe Fly
Ovid Therapeutics price target lowered to $3 from $9 at H.C. Wainwright
3M ago
TAK
OVID
Takeda’s Mixed Results in Soticlestat Trials
PremiumCompany Announcements
Takeda’s Mixed Results in Soticlestat Trials
3M ago
6K
TAK
Ovid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
PremiumThe FlyOvid Therapeutics notes Takeda’s announcement on Phase 3 results of soticlestat
3M ago
TAK
OVID
Takeda says SKYLINE, SKYWAY studies of soticlestat miss primary endpoints
Premium
The Fly
Takeda says SKYLINE, SKYWAY studies of soticlestat miss primary endpoints
3M ago
TAK
Takeda enters exclusive license agreement for olverembatinib with Ascentage
Premium
The Fly
Takeda enters exclusive license agreement for olverembatinib with Ascentage
3M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >